HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea flag South Korea · Delayed Price · Currency is KRW
15,770
+180 (1.15%)
At close: Dec 5, 2025

HLB Pharmaceutical Revenue

In the year 2019, HLB Pharmaceutical had annual revenue of 36.10B KRW with 75.75% growth. HLB Pharmaceutical had revenue of 60.59B in the quarter ending September 30, 2025, with 69.38% growth.

Revenue
36.10B
Revenue Growth
+75.75%
P/S Ratio
6.13
Revenue / Employee
n/a
Employees
n/a
Market Cap
221.45B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 201936.10B15.56B75.75%
Dec 31, 201820.54B4.98B32.03%
Dec 31, 201715.56B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition